Concluding this article, I would like to emphasize an important trend in the development of healthcare technologies, which actualizes the above considerations: the transition to personalized medicine, including with the active introduction of gene therapy, it will be accompanied by a significant increase in costs on the one hand, and on the other hand, a saturation of the range of possible alternative technologies even within narrow groups of patients, which for healthcare organizers will mean the need for more and more detailed calculations.
← all excerpts
Patient Flows, Patient Distribution Computations and Medicines Accounting in the Pharmacoeconomic Models Through Procurement Perspective.
1
—
—